Show simple item record

dc.contributor.authorBeltrame, Ana Lucia
dc.contributor.authorSerafini, Paulo
dc.contributor.authorMotta, Eduardo L. A. [UNIFESP]
dc.contributor.authorSoares Junior, Jose Maria [UNIFESP]
dc.contributor.authorBaracat, Edmund C.
dc.date.accessioned2016-01-24T14:31:23Z
dc.date.available2016-01-24T14:31:23Z
dc.date.issued2013-03-01
dc.identifierhttp://dx.doi.org/10.3109/09513590.2012.736554
dc.identifier.citationGynecological Endocrinology. New York: Informa Healthcare, v. 29, n. 3, p. 201-204, 2013.
dc.identifier.issn0951-3590
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/36073
dc.description.abstractThe aim of this study was to evaluate the effects of bromocriptine on vascular endothelial growth factor (VEGF) levels in serum, kidney function and ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Twenty-eight women were randomly divided into two groups and were administered daily oral capsules for 14 days, starting on the day of human chorionic gonadotropin (hCG) administration. Group A received 2.0 mg of folic acid, whereas Group B was given 2.5 mg of bromocriptine. Physical exams, pelvic ultrasounds and laboratory evaluations were performed on the day of hCG administration and again 7 days later. No differences in ovarian hyperstimulation syndrome, urine volume, creatinine clearance, urine sodium concentration or serum VEGF levels were found between the two groups. Thus, these results indicate that bromocriptine does not affect blood levels of VEGF, kidney function or the incidence of ovarian hyperstimulation syndrome in high-risk patients subjected to in vitro fertilization.en
dc.format.extent201-204
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.ispartofGynecological Endocrinology
dc.rightsAcesso restrito
dc.subjectBromocriptineen
dc.subjectfertilizationen
dc.subjecthyperstimulation syndromeen
dc.subjectkidney functionen
dc.subjectVEGFen
dc.titleThe effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot studyen
dc.typeArtigo
dc.rights.licensehttp://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniv São Paulo, Sch Med, Dept Obstet & Gynecol, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Gynecol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Gynecol, São Paulo, Brazil
dc.identifier.doi10.3109/09513590.2012.736554
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000315166800004


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record